XML 60 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS [Abstract]      
Revenue $ 12,367us-gaap_Revenues $ 3,549us-gaap_Revenues $ 242us-gaap_Revenues
Cost of revenue 3,344us-gaap_CostOfRevenue 2,509us-gaap_CostOfRevenue 201us-gaap_CostOfRevenue
Gross profit 9,023us-gaap_GrossProfit 1,040us-gaap_GrossProfit 41us-gaap_GrossProfit
Operating expenses:      
Research and development expenses, net 15,074us-gaap_ResearchAndDevelopmentExpense 12,275us-gaap_ResearchAndDevelopmentExpense 9,442us-gaap_ResearchAndDevelopmentExpense
Marketing and business development expenses 838us-gaap_BusinessDevelopment 962us-gaap_BusinessDevelopment 684us-gaap_BusinessDevelopment
General and administrative expenses 5,448us-gaap_GeneralAndAdministrativeExpense 4,846us-gaap_GeneralAndAdministrativeExpense 3,457us-gaap_GeneralAndAdministrativeExpense
Total operating expenses 21,360us-gaap_OperatingExpenses 18,083us-gaap_OperatingExpenses 13,583us-gaap_OperatingExpenses
Operating loss (12,337)us-gaap_OperatingIncomeLoss (17,043)us-gaap_OperatingIncomeLoss (13,542)us-gaap_OperatingIncomeLoss
Financial income (loss), net 1,758cgen_FinancialIncomeExpenseNet 3,460cgen_FinancialIncomeExpenseNet (86)cgen_FinancialIncomeExpenseNet
Equity loss (155)us-gaap_IncomeLossFromEquityMethodInvestments      
Loss before tax expenses (10,734)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest (13,583)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest (13,628)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income taxes (360)us-gaap_IncomeTaxExpenseBenefit (500)us-gaap_IncomeTaxExpenseBenefit   
Net loss (11,094)us-gaap_NetIncomeLoss (14,083)us-gaap_NetIncomeLoss (13,628)us-gaap_NetIncomeLoss
Basic net loss per share $ (0.23)us-gaap_EarningsPerShareBasic $ (0.36)us-gaap_EarningsPerShareBasic $ (0.38)us-gaap_EarningsPerShareBasic
Diluted net loss per share $ (0.26)us-gaap_EarningsPerShareDiluted $ (0.36)us-gaap_EarningsPerShareDiluted $ (0.38)us-gaap_EarningsPerShareDiluted
Other comprehensive loss:      
Unrealized gain (loss) arising during the period on the investment in Evogene (1,202)us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax 2,972us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax 1,103us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
Realized gain arising during the period on the investment in Evogene (2,345)us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax (3,711)us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax   
Unrealized gain arising during the period from foreign currency derivative contracts 141us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax      
Total comprehensive loss $ (14,500)us-gaap_ComprehensiveIncomeNetOfTax $ (14,822)us-gaap_ComprehensiveIncomeNetOfTax $ (12,525)us-gaap_ComprehensiveIncomeNetOfTax
Weighted average number of ordinary shares used in computing basic net loss per share 47,808,855us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 38,869,438us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 35,844,496us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
Weighted average number of ordinary shares used in computing diluted net loss per share 48,387,063us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 38,869,438us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 36,249,262us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding